Valuation: Genpharmasec Limited

Market Cap 432M 4.54M 3.97M 3.64M 3.4M 6.44M 6.54M 43.75M 17.01M 212M 17.03M 16.66M 732M P/E 2024
-545x
P/E 2025 94.5x
Enterprise Value 422M 4.44M 3.88M 3.56M 3.32M 6.3M 6.4M 42.8M 16.64M 208M 16.66M 16.3M 716M EV / Sales 2024
3.47x
EV / Sales 2025 2.96x
Free-Float
55.34%
Yield 2024 *
-
Yield 2025 -
1 day-2.63%
1 week+2.78%
Current month+0.91%
1 month-3.48%
3 months+3.74%
6 months-17.16%
Current year-15.27%
1 week 1.08
Extreme 1.08
1.19
1 month 1.03
Extreme 1.03
1.2
Current year 0.75
Extreme 0.75
1.45
1 year 0.75
Extreme 0.75
2.2
3 years 0.75
Extreme 0.75
8.71
5 years 0.75
Extreme 0.75
12.4
10 years 0.75
Extreme 0.75
18
Manager TitleAgeSince
Director of Finance/CFO 38 2022-10-31
Compliance Officer - 2024-03-26
Director TitleAgeSince
Director/Board Member 57 2019-01-01
Director/Board Member 58 2019-01-01
Director/Board Member - 2022-10-31
Change 5-day change 1-year change 3-year change Capi.($)
-2.63%+2.78%-46.12%-68.01% 6.63M
+3.49%+1.36%-29.04%-11.02% 166B
+5.04%+2.73%-5.88%-4.53% 106B
+2.80%+3.63%+0.09%+55.31% 57.69B
+1.33%+1.39%+53.16%+49.84% 53.2B
+3.39%+1.39%-10.26%-39.65% 43.56B
+3.50%+11.11% - - 36.52B
+3.47%+1.58%-14.08%-43.91% 27.49B
+0.20%+4.24%+64.56%-3.33% 25.84B
+2.78%+1.17%-8.15%-0.43% 21.27B
Average +2.34%+4.42%+0.48%-7.30% 53.82B
Weighted average by Cap. +3.31%+3.46%-3.90%+0.99%

Financials

2024 2025
Net sales 304M 3.19M 2.79M 2.57M 2.39M 4.54M 4.6M 30.8M 11.97M 149M 11.99M 11.73M 515M 337M 3.54M 3.1M 2.85M 2.65M 5.03M 5.11M 34.16M 13.28M 166M 13.29M 13.01M 571M
Net income -1.26M -13.2K -11.54K -10.61K -9.89K -18.75K -19.04K -127K -49.5K -618K -49.55K -48.49K -2.13M 12.31M 129K 113K 104K 96.83K 184K 186K 1.25M 485K 6.05M 485K 475K 20.85M
Net Debt -179M -1.88M -1.64M -1.51M -1.41M -2.67M -2.71M -18.12M -7.04M -87.92M -7.05M -6.9M -303M -9.4M -98.76K -86.33K -79.34K -73.95K -140K -142K -952K -370K -4.62M -371K -363K -15.93M
Logo Genpharmasec Limited
Genpharmasec Limited is an India-based company, which is engaged in the distribution of diagnostic pharma equipment and trading of securities. The Company’s segments include Pharmaceuticals, Trading in Securities, and Laboratory Testing. The Trading in Securities segment invests in the secondary securities market. The Company holds rights to the distribution of equipment, such as i-STAT Analyzers and its Cartridges, manufactured by Abbott Point of Care, USA, all over India. The i-STAT Analyzer is a blood analyzer used in Intensive Care Units (ICUs) of hospitals and provides test results in approximately 10 minutes. The Company’s wholly owned subsidiary includes M/s. Clinigenome India Private Limited.
Employees
10
Date Price Change Volume
26-07-03 ₹1.110 -2.63% 160,840
26-07-02 ₹1.140 +3.64% 709,814
26-07-01 ₹1.100 0.00% 200,865
26-06-30 ₹1.100 -0.90% 229,743
26-06-29 ₹1.110 +2.78% 310,922
  1. Stock Market
  2. Stocks
  3. 531592 Stock